Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Medicine Man Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -9.09%.
The historical rank and industry rank for Medicine Man Technologies's ROC (Joel Greenblatt) % or its related term are showing as below:
SHWZ's ROC (Joel Greenblatt) % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12.47 * Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
Medicine Man Technologies's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
Medicine Man Technologies (OTCPK:SHWZ) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Medicine Man Technologies ROC (Joel Greenblatt) % Related Terms
Medicine Man Technologies ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Medicine Man Technologies's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicine Man Technologies ROC (Joel Greenblatt) % Chart
SHWZ vs HEWA, RDGT, SSY: ROC (Joel Greenblatt) % Comparison
For the Pharmaceutical Retailers subindustry, Medicine Man Technologies's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicine Man Technologies ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicine Man Technologies's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Medicine Man Technologies's ROC (Joel Greenblatt) % falls into.
Medicine Man Technologies ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of -9.09% mean?
Medicine Man Technologies (SHWZ) has a ROC (Joel Greenblatt) % of -9.09% as of Jun. 2024. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medicine Man Technologies and its competitors.
Is Medicine Man Technologies' ROC (Joel Greenblatt) % too high?
Medicine Man Technologies' current ROC (Joel Greenblatt) % is -9.09%. Overall, Medicine Man Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medicine Man Technologies' ROC (Joel Greenblatt) % compare to HEWA and RDGT?
Medicine Man Technologies' ROC (Joel Greenblatt) % of -9.09% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROC (Joel Greenblatt) % is 12.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medicine Man Technologies and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicine Man Technologies's current ROC (Joel Greenblatt) % is -9.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicine Man Technologies stock overvalued right now?
Medicine Man Technologies (SHWZ) has a current ROC (Joel Greenblatt) % of -9.09%. The current ROC (Joel Greenblatt) % is -9.09%. Medicine Man Technologies' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Medicine Man Technologies (SHWZ), the current ROC (Joel Greenblatt) % is -9.09% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company's business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.
12GF Score
Get the complete analysis for SHWZ
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHWZ has been successfully added to your 
